alexa
Reach Us +441414719275
Modification Of The Bovine Genome For Large-scale Production Of Human Serum Albumin | 9620
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Modification of the bovine genome for large-scale production of human serum albumin

2nd International Conference on Tissue Science & Regenerative Medicine

Shaida Moghaddassi, Will Eyestone and Colin E. Bishop

ScientificTracks Abstracts: J Tissue Sci Eng

DOI: 10.4172/2157-7552.S1.010

Abstract
T here is a vast clinical need for human serum albumin (HSA) with nearly 500 metric tons used worldwide every year. Currently, HSA is isolated from donated human blood/plasma, a source that fluctuates unpredictably and can potentially spread pathogens from donor to recipient. One solution to the problem is the use of transgenic cattle as living bioreactors, enabling large-scale production of recombinant HSA (rHSA) in a cost-effective manner. Previous simple bovine transgenics which express rHSA in the milk have not proved commercially viable due to the presence of endogenous bovine serum albumin (BSA), resulting in a prohibitively expensive and tedious purification process. Ultimately, this project intends to provide proof- of-principle for production of an inexpensive, reliable, and quality-controlled therapeutic source of rHSA through proposal of the following: 1) Replace endogenous BSA expression with rHSA expression using transcription activator-like effector nuclease (TALEN)-stimulated homologous recombination 2) Direct rHSA expression into the milk using a milk-specific alpha-lactalbumin promoter 3) Produce transgenic bovine embryos from modified fibroblasts using somatic cell nuclear transfer (SCNT)
Biography
Shaida Moghaddassi is a Ph.D. candidate in the Molecular Genetics program at Wake Forest University and is completing her dissertation under direction of Dr. Colin E. Bishop. She graduated with a B.S. in Biological Sciences from Clemson University in 2008
Top